CompletedPhase 3NCT00569582
A Study of the Efficacy and Safety of CORLUX in the Treatment of Endogenous Cushing's Syndrome
Studying OBSOLETE: Cushing syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Corcept Therapeutics
- Principal Investigator
- Coleman GrossCorcept Therapeutics
- Intervention
- mifepristone(drug)
- Enrollment
- 50 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2007
Study locations (17)
- University of Alabama at Birmingham School of Medicine, Birmingham, Alabama, United States
- AMCR Institute Inc., Escondido, California, United States
- Stanford University Medical Center, Stanford, California, United States
- The Center for Diabetes and Endocrine Care, Hollywood, Florida, United States
- Northwestern University Feinberg Medical; Division of Endocrinology, Metabolism & Molecular Medicine, Chicago, Illinois, United States
- The University of Chicago, Chicago, Illinois, United States
- Sinai Hospital of Baltimore, Baltimore, Maryland, United States
- Massachusetts General Hospital, Boston, Massachusetts, United States
- University of Michigan Medical Center, Ann Arbor, Michigan, United States
- University of Mississippi Medical Center, Jackson, Mississippi, United States
- University of New Mexico HSC, Albuquerque, New Mexico, United States
- Cleveland Clinic Foundation; Dept of Endocrinology, Diabetes & Metabolism, Cleveland, Ohio, United States
- Oklahoma University Health Science Center, Oklahoma City, Oklahoma, United States
- Oregon Health Sciences University, Portland, Oregon, United States
- University of Texas Southwestern Medical Center, Dallas, Texas, United States
- +2 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00569582 on ClinicalTrials.govOther trials for OBSOLETE: Cushing syndrome
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT07296484Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)Sparrow Pharmaceuticals
- RECRUITINGNCT07156370Salivary Cortisol and Hypercortisolism in Type 2 DiabetesShanghai 6th People's Hospital
- RECRUITINGPHASE1, PHASE2NCT07350707Diagnostic Value of CXCR4-targeted PET/CT in ACTH-dependent and Independent Cushing's SyndromePeking Union Medical College Hospital
- ACTIVE NOT RECRUITINGNANCT05315388Effects of "Vitamin N" Nature Immersion Therapy on Stress Levels in Health Care Workers in the City of BogotáJeadran N. Malagón-Rojas
- ACTIVE NOT RECRUITINGNCT05382156Non-interventional Study on Osilodrostat in Patients With Endogenous Cushing's SyndromeRECORDATI GROUP
- RECRUITINGNANCT05368090Endoscopic Ultrasound-guided Radiofrequency Ablation in Primary AldosteronismHaukeland University Hospital